athenahealth and Smile Foundation’s mobile healthcare unit, Smile on Wheels, has served more than 10,000 patients in Chennai, India, since launching last year The partnership represents one of several initiatives athenahealth supports in India through its CSR program, athenaGives WATERTOWN, Mass.–(BUSINESS WIRE)–athenahealth, Inc., a leading provider of network-enabled software and services for medical groups and … [Read more…]
IFM is leading the field of functional medicine and advancing the transformation of health and well-being for all. FEDERAL WAY, Wash.–(BUSINESS WIRE)–The Institute for Functional Medicine (IFM) released its highly anticipated 2020-2021 Annual Report showcasing critically important mission-driven work to empower confident and competent practitioners of functional medicine, advance health equity, increase access, and improve … [Read more…]
ROCKVILLE, Md.–(BUSINESS WIRE)–SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of diagnostics for neurological disorders and conditions, including Alzheimer’s disease (AD), is pleased to acknowledge Alzheimer’s & Brain Awareness Month in June as an opportunity to raise awareness about brain disorders including AD and other dementias as a major … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Medical Device Markets for Near Field Communication” report has been added to ResearchAndMarkets.com’s offering. For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient’s quality-of-life. Connected devices – drug injection devices … [Read more…]
DALLAS–(BUSINESS WIRE)–Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases announces that Dr. Hubert Chen, MD has joined the company as Chief Scientific Officer and President. “Dr. Chen is a very accomplished drug development scientist and physician and we are very fortunate that he has agreed to join the Forte team,” … [Read more…]
Company Named as a Specialty Pharmacy to Distribute Newly FDA-Approved Oral Suspension Treatment for Amyotrophic Lateral Sclerosis (ALS) FRISCO, Texas–(BUSINESS WIRE)–#ComplexCare—Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it was named one of only four limited distribution drug (LDD) specialty pharmacy partners to dispense nationwide RADICAVA ORS® (edaravone) … [Read more…]
Funds Will Accelerate Market Penetration and Novel Technology Development to Improve Diagnostic Sample Collection and Processing Workflows WALTHAM, Mass.–(BUSINESS WIRE)–#acceleratecovidtesting–Rhinostics Inc., pioneers in bringing efficiencies to sample collection through modernized technologies, announced the first closing of its Series A-2 financing round, led by Shadow Capital, a new life science technology-focused venture firm making investments in … [Read more…]
ENX-101 exhibited a favorable safety and pharmacokinetic profile in healthy volunteers ENX-101 was well tolerated following once-daily oral administration with no dose titration Translational biomarker data indicated target engagement consistent with anti-seizure activity Engrail plans to initiate the ENACT phase 2 trial in epilepsy SAN DIEGO–(BUSINESS WIRE)–Engrail Therapeutics™ (Engrail) (the Company), a precision neuroscience company … [Read more…]
– Round led by Northpond Ventures with participation from new investors Amgen Ventures, Hatteras Venture Partners and UCB Ventures alongside existing investors – Proceeds will enable Code Bio to advance its lead programs in Duchenne Muscular Dystrophy (DMD) and type 1 diabetes (T1D) towards IND-enabling studies, expand its pipeline and platform applications, and further scale … [Read more…]
Industry Veteran Will Lead Sourcing Strategy for the Firm’s Healthcare Group BOSTON–(BUSINESS WIRE)–Thomas H. Lee Partners, L.P. (“THL”), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Sam Hendler as Managing Director and Head of Business Development for the firm’s healthcare investment group. Hendler, who brings over 20 years … [Read more…]
